Application of CRISPR/Cas system in iPSC-based disease model of hereditary deafness 9

CRISPR/Cas9; Deafness; Disease modeling; Gene editing; Gene therapy; Hearing loss; Human embryonic stem cell; Induced pluripotent stem cell; Inner ear hair cell; Organoid; Otic progenitors; Sensorineural

Abstract :

[en] Sensorineural hearing loss (SNHL) is the most prevalent sensory disorders affecting w 6% of the world population with partial or complete hearing impairment. The molecular etiologies of SNHL could be inherited genetic or acquired environmental factors. The broadening spectrum of genetic causes of SNHL requires a better understanding of the disease pathogenesis and the development of therapeutic targets. To achieve this, we need an experimental humanoid disease model that is fast and easy to perform genetic manipulation and downstream. In this chapter, we discuss how two revolutionary techniques CRISPR/Cas-based gene editing and human-induced pluripotent cells (hiPSCs) could be implemented and reshape the experimental disease model of hearing loss with a vision toward the development of reliable and sustainable therapeutic approaches.

Research Center/Unit :

GIGA Stem Cells-Developmental Neurobiology - ULiège

Disciplines :

Otolaryngology
Biochemistry, biophysics & molecular biology

Author, co-author :

Giri, Subhajit ; Université de Liège - ULiège > Département des sciences cliniques > Neurologie

Malgrange, Brigitte ; Université de Liège - ULiège > GIGA > GIGA Neurosciences

Language :

English

Title :

Application of CRISPR/Cas system in iPSC-based disease model of hereditary deafness 9

Publication date :

2022

Main work title :

iPSCs - State of the Science

Author, co-author :

Birbrair, Alexander

Publisher :

academic press

ISBN/EAN :

978-0-323-85767-3

Collection name :

Volume 16 in Advances in Stem Cell Biology

Peer reviewed :

Peer reviewed

Available on ORBi :

since 15 March 2022

Statistics

Number of views

65 (2 by ULiège)

Number of downloads

113 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Amabile A., et al. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 2016, 167:219-232.e214. 10.1016/j.cell.2016.09.006.
Anzalone A.V., et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 2019, 576:149-157. 10.1038/s41586-019-1711-4.
Ardhanareeswaran K., Mariani J., Coppola G., Abyzov A., Vaccarino F.M. Human induced pluripotent stem cells for modelling neurodevelopmental disorders. Nat. Rev. Neurol. 2017, 13:265-278. 10.1038/nrneurol.2017.45.
Barrangou R., et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007, 315:1709-1712. 10.1126/science.1138140.
Bok J., et al. Opposing gradients of Gli repressor and activators mediate Shh signaling along the dorsoventral axis of the inner ear. Development 2007, 134:1713. 10.1242/dev.000760.
Brassard J.A., Lutolf M.P. Engineering stem cell self-organization to build better organoids. Cell Stem Cell 2019, 24:860-876. 10.1016/j.stem.2019.05.005.
Burstein D., et al. New CRISPR-Cas systems from uncultivated microbes. Nature 2017, 542:237-241. 10.1038/nature21059.
Cano-Rodriguez D., et al. Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner. Nat. Commun. 2016, 7:12284. 10.1038/ncomms12284.
Casini A., et al. Ahighly specific SpCas9 variant is identified by invivo screening in yeast. Nat. Biotechnol. 2018, 36:265-271. 10.1038/nbt.4066.
Chadwick A.C., Wang X., Musunuru K. Invivo base editing of PCSK9 (proprotein convertase subtilisin/kexin type 9) as a therapeutic alternative to genome editing. Arterioscler. Thromb. Vasc. Biol. 2017, 37:1741-1747. 10.1161/atvbaha.117.309881.
Chatterjee P., Jakimo N., Jacobson J.M. Minimal PAM specificity of a highly similar SpCas9 ortholog. Sci. Adv. 2018, 4:eaau0766. 10.1126/sciadv.aau0766.
Chavez A., et al. Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 2015, 12:326-328. 10.1038/nmeth.3312.
Chen W., et al. Restoration of auditory evoked responses by human ES-cell-derived otic progenitors. Nature 2012, 490:278-282. 10.1038/nature11415.
Chen J.R., et al. Effects of genetic correction on the differentiation of hair cell-like cells from iPSCs with MYO15A mutation. Cell Death Differ. 2016, 23:1347-1357. 10.1038/cdd.2016.16.
Chen J.S., et al. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature 2017, 550:407-410. 10.1038/nature24268.
Chen J., et al. Differentiation and transplantation of human induced pluripotent stem cell-derived otic epithelial progenitors in mouse cochlea. Stem Cell Res. Ther. 2018, 9:230. 10.1186/s13287-018-0967-1.
Cheng A.W., et al. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res. 2013, 23:1163-1171. 10.1038/cr.2013.122.
Cong L., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819. 10.1126/science.1231143.
Cox D.B.T., Gootenberg J.S. RNA editing with CRISPR-Cas13. Science 2017, 358:1019-1027. 10.1126/science.aaq0180.
Dedhia P.H., Bertaux-Skeirik N., Zavros Y., Spence J.R. Organoid models of human gastrointestinal development and disease. Gastroenterology 2016, 150:1098-1112. 10.1053/j.gastro.2015.12.042.
Ding J., et al. Induction of differentiation of human embryonic stem cells into functional hair-cell-like cells in the absence of stromal cells. Int. J. Biochem. Cell Biol. 2016, 81:208-222. 10.1016/j.biocel.2015.11.012.
Ealy M., Ellwanger D.C., Kosaric N., Stapper A.P., Heller S. Single-cell analysis delineates a trajectory toward the human early otic lineage. Proc. Natl. Acad. Sci. USA 2016, 113:8508-8513. 10.1073/pnas.1605537113.
Essletzbichler P., et al. Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line. Genome Res. 2014, 24:2059-2065. 10.1101/gr.177220.114.
Fujita T., Fujii H. Efficient isolation of specific genomic regions and identification of associated proteins by engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) using CRISPR. Biochem. Biophys. Res. Commun. 2013, 439:132-136. 10.1016/j.bbrc.2013.08.013.
Fukunaga I., et al. Invitro models of GJB2-related hearing loss recapitulate Ca(2+) transients via a gap junction characteristic of developing cochlea. Stem Cell Rep. 2016, 7:1023-1036. 10.1016/j.stemcr.2016.10.005.
Gao X., et al. Treatment of autosomal dominant hearing loss by invivo delivery of genome editing agents. Nature 2018, 553:217-221. 10.1038/nature25164.
Gaudelli N.M., et al. Programmable base editing of AT to GC in genomic DNA without DNA cleavage. Nature 2017, 551:464-471. 10.1038/nature24644.
Géléoc G.S.G., Holt J.R. Sound strategies for hearing restoration. Science 2014, 344:1241062. 10.1126/science.1241062.
Georgomanoli M., Papapetrou E.P. Modeling blood diseases with human induced pluripotent stem cells. Dis. Model Mech. 2019, 12. 10.1242/dmm.039321.
Gilbert L.A., et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 2013, 154:442-451. 10.1016/j.cell.2013.06.044.
Gilbert L.A., et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 2014, 159:647-661. 10.1016/j.cell.2014.09.029.
Halpin-Healy T.S., Klompe S.E., Sternberg S.H., Fernández I.S. Structural basis of DNA targeting by a transposon-encoded CRISPR-Cas system. Nature 2020, 577:271-274. 10.1038/s41586-019-1849-0.
Hilton I.B., et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 2015, 33:510-517. 10.1038/nbt.3199.
Hosoya M., et al. Cochlear cell modeling using disease-specific iPSCs unveils a degenerative phenotype and suggests treatments for congenital progressive hearing loss. Cell Rep. 2017, 18:68-81. 10.1016/j.celrep.2016.12.020.
Hou Z., et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc. Natl. Acad. Sci. USA 2013, 110:15644. 10.1073/pnas.1313587110.
Hu J.H., et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature 2018, 556:57-63. 10.1038/nature26155.
Jeong M., et al. Generating inner ear organoids containing putative cochlear hair cells from human pluripotent stem cells. Cell Death Dis. 2018, 9:922. 10.1038/s41419-018-0967-1.
Jinek M., et al. Aprogrammable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012, 337:816. 10.1126/science.1225829.
Kearns N.A., et al. Functional annotation of native enhancers with a Cas9-histone demethylase fusion. Nat. Methods 2015, 12:401-403. 10.1038/nmeth.3325.
Kim K., et al. Highly efficient RNA-guided base editing in mouse embryos. Nat. Biotechnol. 2017, 35:435-437. 10.1038/nbt.3816.
Kleinstiver B.P., et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 2015, 523:481-485. 10.1038/nature14592.
Kleinstiver B.P., et al. High-fidelity CRISPR-Cas9 nucleases with no detectablegenome-wide off-target effects. Nature 2016, 529:490-495. 10.1038/nature16526.
Koehler K.R., et al. Generation of inner ear organoids containing functional hair cells from human pluripotent stem cells. Nat. Biotechnol. 2017, 35:583-589. 10.1038/nbt.3840.
Koffler T., Ushakov K., Avraham K.B. Genetics of hearing loss: syndromic. Otolaryngol. Clin. North Am. 2015, 48:1041-1061. 10.1016/j.otc.2015.07.007.
Kokotas H., Petersen M.B., Willems P.J. Mitochondrial deafness. Clin. Genet. 2007, 71:379-391. 10.1111/j.1399-0004.2007.00800.x.
Komor A.C., Kim Y.B., Packer M.S., Zuris J.A., Liu D.R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 2016, 533:420-424. 10.1038/nature17946.
Konermann S., et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 2015, 517:583-588. 10.1038/nature14136.
Koonin E.V., Makarova K.S., Zhang F. Diversity, classification and evolution of CRISPR-Cas systems. Curr. Opin. Microbiol. 2017, 37:67-78. 10.1016/j.mib.2017.05.008.
Lahlou H., Lopez-Juarez A., Fontbonne A., Nivet E., Zine A. Modeling human early otic sensory cell development with induced pluripotent stem cells. PLoS One 2018, 13:e0198954. 10.1371/journal.pone.0198954.
Lee J.K., et al. Directed evolution of CRISPR-Cas9 to increase its specificity. Nat. Commun. 2018, 9:3048. 10.1038/s41467-018-05477-x.
Litsiou A., Hanson S., Streit A. Abalance of FGF, BMP and WNT signalling positions the future placode territory in the head. Development 2005, 132:4051. 10.1242/dev.01964.
Liu X.S., et al. Editing DNA methylation in the mammalian genome. Cell 2016, 167:233-247.e217. 10.1016/j.cell.2016.08.056.
Liu M., et al. Methodologies for improving HDR efficiency. Front. Genet. 2018, 9:691. 10.3389/fgene.2018.00691.
Liu X.S., et al. Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene. Cell 2018, 172:979-992.e976. 10.1016/j.cell.2018.01.012.
Lopez-Juarez A., et al. Engraftment of human stem cell-derived otic progenitors in thedamaged cochlea. Mol. Ther. J 2019, 27:1101-1113. 10.1016/j.ymthe.2019.03.018.
Ma H., et al. Multiplexed labeling of genomic loci with dCas9 and engineered sgRNAs using CRISPRainbow. Nat. Biotechnol. 2016, 34:528-530. 10.1038/nbt.3526.
Makarova K.S., Wolf Y.I., Koonin E.V. Classification and nomenclature of CRISPR-Cas systems: where from here. CRISPR J. 2018, 1:325-336. 10.1089/crispr.2018.0033.
Mali P., et al. RNA-guided human genome engineering via Cas9. Science 2013, 339:823. 10.1126/science.1232033.
Martin K., Groves A.K. Competence of cranial ectoderm to respond to Fgf signaling suggests a two-step model of otic placode induction. Development 2006, 133:877. 10.1242/dev.02267.
Mertens J., Reid D., Lau S., Kim Y., Gage F.H. Aging in a dish: iPSC-derived and directly induced neurons for studying brain aging and age-related neurodegenerative diseases. Annu. Rev. Genet. 2018, 52:271-293. 10.1146/annurev-genet-120417-031534.
Michalski N., Petit C. Genes involved in the development and physiology of both the peripheral and central auditory systems. Annu. Rev. Neurosci. 2019, 42:67-86. 10.1146/annurev-neuro-070918-050428.
Mittal R., et al. Recent advancements in the regeneration of auditory hair cells andhearing restoration. Front. Mol. Neurosci. 2017, 10:236. 10.3389/fnmol.2017.00236.
Myers S.A., et al. Discovery of proteins associated with a predefined genomic locus via dCas9-APEX-mediated proximity labeling. Nat. Methods 2018, 15:437-439. 10.1038/s41592-018-0007-1.
Ohnishi H., et al. Limited hair cell induction from human induced pluripotent stem cells using a simple stepwise method. Neurosci. Lett. 2015, 599:49-54. 10.1016/j.neulet.2015.05.032.
Paquet D., et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 2016, 533:125-129. 10.1038/nature17664.
Park S.E., Georgescu A. Organoids-on-a-chip. Science 2019, 364:960-965. 10.1126/science.aaw7894.
Qi L.S., et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 2013, 152:1173-1183. 10.1016/j.cell.2013.02.022.
Ran F.A., et al. Invivo genome editing using Staphylococcus aureus Cas9. Nature 2015, 520:186-191. 10.1038/nature14299.
Rees H.A., et al. Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery. Nat. Commun. 2017, 8:15790. 10.1038/ncomms15790.
Rios A.C., Clevers H. Imaging organoids: a bright future ahead. Nat. Methods 2018, 15:24-26. 10.1038/nmeth.4537.
Roccio M., Edge A.S.B. Inner ear organoids: new tools to understand neurosensory cell development, degeneration and regeneration. Development 2019, 146. 10.1242/dev.177188.
Ronaghi M., et al. Inner ear hair cell-like cells from human embryonic stem cells. Stem Cells Dev. 2014, 23:1275-1284. 10.1089/scd.2014.0033.
Sakagami M., et al. Differentiation of embryonic stem cells into inner ear vestibular hair cells using vestibular cell derived-conditioned medium. Biochem. Biophys. Rep. 2019, 19:100649. 10.1016/j.bbrep.2019.100649.
Sanjurjo-Soriano C., et al. Genome editing in patient iPSCs corrects the most prevalent USH2A mutations and reveals intriguing mutant mRNA expression profiles. Mol. Ther. Methods Clin. Dev. 2020, 17:156-173. 10.1016/j.omtm.2019.11.016.
Schaefer S.A., et al. From otic induction to hair cell production: Pax2(EGFP) cell line illuminates key stages of development in mouse inner ear organoid model. Stem Cells Dev. 2018, 27:237-251. 10.1089/scd.2017.0142.
Sharma A., Wu J.C., Wu S.M. Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening. Stem Cell Res. Ther. 2013, 4:150. 10.1186/scrt380.
Shmakov S., et al. Diversity and evolution of class 2 CRISPR-Cas systems. Nat. Rev. Microbiol. 2017, 15:169-182. 10.1038/nrmicro.2016.184.
Sinkunas T., et al. Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system. EMBO J. 2011, 30:1335-1342. 10.1038/emboj.2011.41.
Slaymaker I.M., et al. Rationally engineered Cas9 nucleases with improved specificity. Science 2016, 351:84-88. 10.1126/science.aad5227.
Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872. 10.1016/j.cell.2007.11.019.
Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676. 10.1016/j.cell.2006.07.024.
Takeda H., Hosoya M., Fujioka M. Engraftment of human pluripotent stem cell-derived progenitors in the inner ear of prenatal mice. Sci. Rep. 2018, 8:1941. 10.1038/s41598-018-20277-5.
Tanenbaum M.E., Gilbert L.A., Qi L.S., Weissman J.S., Vale R.D. Aprotein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 2014, 159:635-646. 10.1016/j.cell.2014.09.039.
Tang Z.H., et al. Genetic correction of induced pluripotent stem cells from a deaf patient with MYO7A mutation results in morphologic and functional recovery of the derived hair cell-like cells. Stem Cells Transl. Med. 2016, 5:561-571. 10.5966/sctm.2015-0252.
Tang P.C., et al. Defective Tmprss3-associated hair cell degeneration in inner ear organoids. Stem Cell Rep. 2019, 13:147-162. 10.1016/j.stemcr.2019.05.014.
Thakore P.I., et al. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat. Methods 2015, 12:1143-1149. 10.1038/nmeth.3630.
Torres R., et al. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system. Nat. Commun. 2014, 5:3964. 10.1038/ncomms4964.
Vakulskas C.A., et al. Ahigh-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nat. Med. 2018, 24:1216-1224. 10.1038/s41591-018-0137-0.
Venkatesh M.D., Moorchung N., Puri B. Genetics of non syndromic hearing loss. Med. J. Armed Forces India 2015, 71:363-368. 10.1016/j.mjafi.2015.07.003.
Wang A., et al. Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. Science 1998, 280:1447-1451. 10.1126/science.280.5368.1447.
Wu D.K., Kelley M.W. Molecular mechanisms of inner ear development. Cold Spring Harb Perspect. Biol. 2012, 4:a008409. 10.1101/cshperspect.a008409.
Yamada M., et al. Crystal structure of the minimal Cas9 from Campylobacter jejuni reveals the molecular diversity in the CRISPR-Cas9 systems. Mol. Cell 2017, 65:1109e1103-1121e1103. 10.1016/j.molcel.2017.02.007.
Yang L.Z., et al. Dynamic imaging of RNA in living cells by CRISPR-Cas13 systems. Mol. Cell 2019, 76:981e987-997e987. 10.1016/j.molcel.2019.10.024.
Yeh W.-H., Chiang H., Rees H.A., Edge A.S.B., Liu D.R. Invivo base editing of post-mitotic sensory cells. Nat. Commun. 2018, 9:2184. 10.1038/s41467-018-04580-3.
Yin X., et al. Engineering stem cell organoids. Cell Stem Cell 2016, 18:25-38. 10.1016/j.stem.2015.12.005.
Yu F., Hunziker W. Engineering microfluidic organoid-on-a-chip platforms. Micromachines 2019, 10. 10.3390/mi10030165.
Zetsche B., et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 2015, 163:759-771. 10.1016/j.cell.2015.09.038.